GHK-Cu Half-Life: How Long It Lasts

Free GHK-Cu circulating in plasma has a half-life of approximately 30 minutes. Plasma levels of GHK decline from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60, which parallels the decline in tissue regenerative capacity (Pickart, 2008). If you stopped the story here, you would conclude that GHK-Cu is a peptide that flashes through the bloodstream and vanishes. That is not how the molecule actually behaves.

The 30-minute figure applies to the free, unbound tripeptide in plasma. In reality, most of the injected GHK-Cu rapidly binds to albumin and other plasma proteins. Albumin itself has a half-life of 19 to 21 days, and when a small peptide hitches a ride on albumin, its effective circulating half-life extends to 4 to 6 hours before it distributes into tissue.

Peak plasma concentration after a subcutaneous injection is reached at 30 to 60 minutes. The peptide then redistributes from blood to target tissues (skin, dermal fibroblasts, wound sites, connective tissue) over the next 2 to 4 hours. By 6 hours post-injection, plasma levels are minimal but tissue-level GHK-Cu is high and working.

This distribution pattern is why blood tests are useless for monitoring GHK-Cu therapy. The peptide is not supposed to be in your blood 8 hours after injection. It is supposed to be in your skin, your tendons, your wound bed, doing its work.

GHK-Cu acts locally. Its job is to bind copper in a specific, bioavailable form and deliver it to copper-dependent enzymes at the cellular level. Lysyl oxidase needs copper to cross-link collagen. Superoxide dismutase (SOD) needs copper to neutralize free radicals. Cytochrome c oxidase needs copper for mitochondrial energy production. GHK-Cu stimulates collagen synthesis in fibroblasts at concentrations as low as 10^-12 M, with maximal stimulation at 10^-9 M (Maquart et al., 1988).

The tripeptide-copper complex delivers copper where it needs to go, then gets recycled back to plasma or degraded by peptidases. This recycling is what produces the 24 to 48-hour effective window.

Skin and dermal tissue: GHK-Cu is retained at active fibroblasts for 24 to 48 hours after a single dose. This is why daily injection (or injection every 48 hours for maintenance) works. Collagen synthesis stimulation continues long after plasma levels are undetectable.

Wound beds and connective tissue: Retention is even longer at sites of active repair. GHK-Cu has been documented to drive angiogenesis signaling and tissue regeneration at wound sites for prolonged periods after a single application (Pickart & Margolina, 2018).

Hair follicles: Retention time parallels the follicular growth cycle. Topical GHK-Cu applied at bedtime remains bioavailable to hair bulb cells through the anagen phase proliferation window. See GHK-Cu hair growth for the full hair protocol.

Liver and kidney: GHK-Cu is cleared primarily by hepatic peptidases. A small fraction is renally excreted unchanged. Elimination is essentially complete within 24 hours.

The practical implication: even if you miss a dose by 24 hours, therapeutic tissue levels are still active. You do not need to "catch up" or double-dose.

The tissue half-life window is the reason standard GHK-Cu protocols run once-daily (or 5-days-on, 2-days-off) rather than more frequent dosing.

Daily injection (1 to 2 mg SC): The standard protocol for skin rejuvenation, hair growth, and general anti-aging. Tissue levels build to steady state within 5 to 7 days. This is the default.

Every-other-day (2 mg SC): A valid alternative that leverages the 48-hour tissue retention window. Slightly cheaper (fewer injections, same total weekly dose) and equally effective for chronic maintenance. Used by people who dislike daily injections.

Twice-daily dosing (splitting the daily dose): Not standard and not needed for most applications. The only context where BID GHK-Cu makes sense is acute wound healing or post-surgical recovery where sustaining maximal tissue concentration matters more than convenience.

Frequency should match your goal, not the plasma half-life. For skin, daily is enough. For acute tendon injury, daily or BID during the first 2 weeks then taper. For chronic anti-aging, daily or every-other-day indefinitely. See GHK-Cu injection frequency for the full frequency-by-goal breakdown.

What does not work: Stacking 2 mg + 2 mg twice-daily thinking it will double the effect. Receptor saturation at the fibroblast level occurs around 1 to 2 mg equivalent. Anything above that does not produce proportionally more collagen synthesis; it just increases injection volume and cost.

Topical GHK-Cu (serums, creams, and microneedling-delivered formulations) behaves differently than injectable. The peptide is delivered directly to the stratum corneum and penetrates through the epidermis to the dermis where fibroblasts live.

Skin retention duration: A properly formulated topical GHK-Cu serum provides 8 to 24 hours of bioavailable peptide at the fibroblast level after a single application. Nighttime application maximizes the 6 to 8-hour uninterrupted contact window.

Penetration time to dermis: 30 to 90 minutes for standard serum formulations. Faster with penetration enhancers (hyaluronic acid, DMSO) or mechanical disruption (microneedling). Slower if applied under heavy occlusive moisturizers.

Why evening application wins: Mitotic and repair activity in skin peaks between 10 PM and 2 AM. Applying GHK-Cu at bedtime aligns peptide retention with peak fibroblast activity. See GHK-Cu microneedling for how mechanical delivery extends effective dosing windows.

Formulation pH matters: GHK-Cu is most stable between pH 6.5 and 7.5. Acidic serums (vitamin C, AHAs) degrade the copper-peptide bond within hours. If you use both, apply GHK-Cu first, wait 15 minutes, then layer the acidic actives.

Sunscreens interfere. Zinc oxide and avobenzone disrupt the copper-peptide coordination. Morning topical GHK-Cu application under sunscreen wastes the product. Evening is the only effective topical window.

When people ask "how long does GHK-Cu last," they sometimes mean vial stability rather than in-body pharmacokinetics. Both matter.

Unreconstituted lyophilized GHK-Cu: 2+ years at room temperature if kept dry and dark. Lyophilized (freeze-dried) peptide is extremely stable. Most vials ship with a 2-year expiration date, but peptide integrity often exceeds that. Light and humidity are the enemies.

Reconstituted with bacteriostatic water, refrigerated: 28 days is the conservative estimate used by most providers. Real-world stability data suggests 30 to 60 days without significant degradation when stored at 2 to 8 degrees Celsius in the original vial.

Reconstituted with sterile water (not bacteriostatic): 24 to 48 hours maximum. Sterile water has no preservative. Bacterial growth and peptide degradation accelerate after the first day. Use sterile water only if you plan to finish the vial within 48 hours, otherwise bacteriostatic water is standard. See bacteriostatic water vs sterile water.

Reconstituted and left at room temperature: 24 to 48 hours is the maximum. The copper-peptide bond is heat-sensitive. A vial left on the counter degrades faster than one in the fridge. Discard any reconstituted vial that has been unrefrigerated for more than 48 hours.

How to tell if a reconstituted vial has gone bad: GHK-Cu has a characteristic blue color (copper). A properly reconstituted solution is pale blue and clear. If the solution turns dark blue, cloudy, or develops visible particles, the peptide has degraded. Discard.

For the complete reconstitution protocol with volume ratios and syringe sizing, see how to reconstitute GHK-Cu and how long do reconstituted peptides last.

The 30-minute plasma half-life has an upside: systemic side effects resolve quickly. Any transient reaction to injection (mild flushing, temporary fatigue, injection site sensation) peaks within 30 to 60 minutes and resolves within 2 to 4 hours.

What you might feel during peak plasma: - Mild warmth at injection site (vasodilation) - Brief metallic taste (some users, linked to copper) - Slight fatigue in the first week (rare, mechanism unclear)

What resolves within 4 hours: - All transient systemic effects - Injection site sensation (vasodilation-mediated)

What persists because it is tissue-level, not plasma-level: - Wanted effects: collagen synthesis, fibroblast activation, wound healing signals - Unwanted effects (at copper-sensitive individuals): theoretical copper accumulation with chronic high-dose use, though this is not documented in standard 1 to 2 mg daily protocols

The mismatch between plasma and tissue pharmacokinetics also explains why side effects from GHK-Cu are usually not dose-sensitive in the narrow therapeutic range. Doubling a 1 mg dose to 2 mg does not double the "felt" effects because receptor saturation occurs at tissue, not plasma.

For the full side effect profile and safety limitations, see GHK-Cu side effects.